We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » UK’s RECOVERY Trial Cuts Antibiotic Azithromycin, Finding No Benefit for Severe COVID-19
UK’s RECOVERY Trial Cuts Antibiotic Azithromycin, Finding No Benefit for Severe COVID-19
Researchers with the UK’s multi-armed RECOVERY trial have determined that the widely used antibiotic azithromycin was not beneficial for patients hospitalized with COVID-19 and are discontinuing their evaluation of the drug.